• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

促甲状腺素抑制疗法用于治疗伴有巨大复发性颈部淋巴结的乳头状甲状腺癌。

Thyrotropin suppression therapy for papillary thyroid carcinoma with a huge recurred neck lymph node.

作者信息

Choi Jung Bum, Kim Dong-Il, Paik Hyun-June, Lee Seung Joo, Jung Chang Shin, Kang Seok Kyung, Jung Youn Joo, Kim Hyun Yul

机构信息

Department of Surgery, Pusan National University Hospital, Busan, Korea.

Department of Surgery, Pusan National University Yangsan Hospital, Yangsan, Korea.

出版信息

Korean J Clin Oncol. 2020 Dec;16(2):145-147. doi: 10.14216/kjco.20023. Epub 2020 Dec 31.

DOI:10.14216/kjco.20023
PMID:36945712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9942732/
Abstract

Differentiated thyroid cancer (DTC) originating from thyroid tissue is affected by thyrotropin (TSH). TSH suppression therapy is usually recommended after thyroidectomy in cases of DTC. A 57-year-old woman who harbored a very huge recurred lymph node underwent TSH suppression therapy because of the risk of surgical complications. After TSH suppression, the huge neck lymph node exhibited a response and decreased in size. She had been followed up for 144 months. TSH suppression therapy could be considered as an alternative treatment option in a recurred DTC patient with a high perioperative risk.

摘要

起源于甲状腺组织的分化型甲状腺癌（DTC）受促甲状腺激素（TSH）影响。对于DTC患者，通常建议在甲状腺切除术后进行TSH抑制治疗。一名57岁女性因存在手术并发症风险，对其复发的巨大淋巴结进行了TSH抑制治疗。TSH抑制治疗后，颈部巨大淋巴结出现反应并缩小。对她进行了144个月的随访。对于围手术期风险高的复发性DTC患者，TSH抑制治疗可被视为一种替代治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4857/9942732/deeadb0dc4cc/kjco-16-2-145f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4857/9942732/275d11f078ef/kjco-16-2-145f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4857/9942732/007e4acee75e/kjco-16-2-145f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4857/9942732/deeadb0dc4cc/kjco-16-2-145f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4857/9942732/275d11f078ef/kjco-16-2-145f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4857/9942732/007e4acee75e/kjco-16-2-145f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4857/9942732/deeadb0dc4cc/kjco-16-2-145f3.jpg

相似文献

1
Thyrotropin suppression therapy for papillary thyroid carcinoma with a huge recurred neck lymph node.促甲状腺素抑制疗法用于治疗伴有巨大复发性颈部淋巴结的乳头状甲状腺癌。
Korean J Clin Oncol. 2020 Dec;16(2):145-147. doi: 10.14216/kjco.20023. Epub 2020 Dec 31.
2
Thyrotropin Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.促甲状腺激素抑制疗法治疗低危小甲状腺癌：一项倾向评分匹配队列研究。
Thyroid. 2017 Sep;27(9):1164-1170. doi: 10.1089/thy.2017.0177. Epub 2017 Aug 8.
3
Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer.术后甲状腺刺激素水平对甲状腺乳头状癌患者甲状腺叶切除术后的复发无影响。
Endocrinol Metab (Seoul). 2019 Jun;34(2):150-157. doi: 10.3803/EnM.2019.34.2.150. Epub 2019 Mar 19.
4
Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin.乳头状和滤泡状（分化型）甲状腺癌的管理：使用重组人促甲状腺素的新范例
Endocr Relat Cancer. 2002 Dec;9(4):227-47. doi: 10.1677/erc.0.0090227.
5
Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma.对于美国甲状腺协会（ATA）低风险和中风险的分化型甲状腺癌患者，促甲状腺激素抑制治疗虽不会降低复发风险，但会增加骨质疏松症的风险。
Thyroid. 2015 Mar;25(3):300-7. doi: 10.1089/thy.2014.0287. Epub 2014 Dec 16.
6
Ectopic thyrotropin secreting pituitary adenoma concomitant with papillary thyroid carcinoma: Case report.异位分泌促甲状腺激素的垂体腺瘤合并甲状腺乳头状癌：病例报告
Medicine (Baltimore). 2017 Dec;96(50):e8912. doi: 10.1097/MD.0000000000008912.
7
Surgical treatment of papillary thyroid carcinoma without lymph nodal involvement.无淋巴结受累的甲状腺乳头状癌的外科治疗
G Chir. 2012 Oct;33(10):339-42.
8
Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.经腋后（TARA）入路机器人辅助施行 Sistrunk 手术、甲状腺全切除术和颈淋巴结清扫术治疗甲状舌管囊肿和甲状腺起源的乳头状癌
Ann Surg Oncol. 2012 Dec;19(13):4259-61. doi: 10.1245/s10434-012-2674-y. Epub 2012 Oct 16.
9
Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.预防性中央区颈淋巴结清扫术在临床淋巴结阴性的乳头状甲状腺癌患者治疗中的临床意义
World J Surg Oncol. 2016 Sep 19;14(1):247. doi: 10.1186/s12957-016-1003-5.
10
Thyroid stimulating hormone suppression and recurrence after thyroid lobectomy for papillary thyroid carcinoma.甲状腺刺激激素抑制与甲状腺叶切除术后甲状腺乳头状癌复发。
Endocrine. 2022 Feb;75(2):487-494. doi: 10.1007/s12020-021-02911-x. Epub 2021 Oct 23.

本文引用的文献

1
Thyroid Hormone Suppression Therapy.甲状腺激素抑制治疗。
Endocrinol Metab Clin North Am. 2019 Mar;48(1):227-237. doi: 10.1016/j.ecl.2018.10.008. Epub 2018 Dec 4.
2
Spontaneous Regression of Metastatic Papillary Thyroid Cancer in a Lymph Node.淋巴结转移性乳头状甲状腺癌的自发消退
Case Rep Endocrinol. 2018 Mar 20;2018:5873897. doi: 10.1155/2018/5873897. eCollection 2018.
3
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南：美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
4
Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.分化型甲状腺癌中促甲状腺激素抑制治疗的获益与不良反应风险。
Thyroid. 2010 Feb;20(2):135-46. doi: 10.1089/thy.2009.0311.
5
Papillary thyroid cancer: surgical management of lymph node metastases.甲状腺乳头状癌：淋巴结转移的外科治疗
Curr Treat Options Oncol. 2005 Jul;6(4):311-22. doi: 10.1007/s11864-005-0035-9.
6
Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases.直径小于1.5厘米的甲状腺乳头状癌的临床行为及预后：299例病例研究
J Clin Endocrinol Metab. 2004 Aug;89(8):3713-20. doi: 10.1210/jc.2003-031982.
7
Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.左甲状腺素对分化型甲状腺癌患者甲状腺球蛋白的抑制作用
J Clin Endocrinol Metab. 1999 Dec;84(12):4549-53. doi: 10.1210/jcem.84.12.6190.
8
Treatment of benign nodular thyroid disease.良性结节性甲状腺疾病的治疗。
N Engl J Med. 1998 May 14;338(20):1438-47. doi: 10.1056/NEJM199805143382007.